⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL899065 | 1.00 | — | — | |
| SCHEMBL3188709 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL8436490 | 0.96 | — | — | |
| SCHEMBL156118 | 0.79 | — | — | |
| SCHEMBL245241 | 0.79 | — | — | |
| SCHEMBL156117 | 0.79 | — | — | |
| SCHEMBL17565650 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL9156886 | 0.75 | — | — | |
| Charcoal, Activated SCHEMBL6391496 | 0.75 | ALDH1A1 (0.47) | — | |
| Hydrochloric Acid SCHEMBL9156875 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119955492-A | Gel blocking agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119955501-A | High-temperature-resistant gel composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119955491-A | Self-repairing gel plugging agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119955492-A | Gel blocking agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119955491-A | Self-repairing gel plugging agent and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119955501-A | High-temperature-resistant gel composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20240025877-A1 | PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED | 2024-01-25 | — | — | US | disclosed |
| US-20230140216-A1 | COMBINATION THERAPY FOR TREATING MPS1 | GAIN THERAPEUTICS SA (CH) | 2023-05-04 | — | — | US | disclosed |
| US-20230140216-A1 | COMBINATION THERAPY FOR TREATING MPS1 | GAIN THERAPEUTICS SA (CH) | 2023-05-04 | — | — | US | disclosed |
| EP-4100015-A1 | COMBINATION THERAPY FOR TREATING MPS1 | Gain Therapeutics SA (CH) | 2022-12-14 | — | — | EP | disclosed |
| CN-115397423-A | Combination therapy for the treatment of MPS1 | 增益治疗股份有限公司 | 2022-11-25 | — | — | CN | disclosed |
| WO-2010007800-A1 | NOVEL URACIL COMPOUND HAVING AMIDE STRUCTURE AND SALT THEREOF | 大鵬薬品工業株式会社 (JP) | 2010-01-21 | — | — | WO | disclosed |
| US-20080261968-A1 | Heterobicyclic metalloprotease inhibitors | GEGE CHRISTIAN | 2008-10-23 | — | — | US | disclosed |
| US-20080221095-A1 | Metalloprotease inhibitors containing a heterocyclic moiety | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080221128-A1 | Metalloprotease inhibitors containing a squaramide moiety | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080207607-A1 | Heterotricyclic metalloprotease inhibitors | ALANTOS PHARMACEUTICALS HOLDING, INC. | 2008-08-28 | — | — | US | disclosed |
| WO-2007070598-A9 | NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS | SPRING BANK (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007070598-A2 | NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS | SPRING BANK (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070037805-A1 | Fused heteroaryl derivatives | HAYAKAWA MASAHIKO | 2007-02-15 | — | — | US | disclosed |
| US-7173029-B2 | Fused heteroaryl derivatives | ASTELLAS PHARMA INC. (JP) | 2007-02-06 | — | — | US | disclosed |